A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

Clinical trial NCT05304377 · RECRUITING

Trial details

NCT number: NCT05304377
Sponsor: Enliven Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Cml

Start date: 2022-05-22
Primary completion: 2027-12-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.